CLK2, active

N-terminal GST-tagged recombinant, human CLK2 amino acids 138-end.

Catalog #: 14-774

$399.00$2,989.00


Inquire
Biological Information
Background Information:
CLK2 (CDC2-like kinases) proteins contain an Serine- and Arginine-rich (SR) domain and autophosphorylate on tyrosine, serine, and threonine residues in overexpression systems and in vitro. Mutations in the clk-2 gene of the nematode Caenorhabditis elegans affect organismal features such as development, behavior, reproduction, and aging as well as cellular features such as the cell cycle, apoptosis, the DNA replication checkpoint, and telomere length. These results suggest the existence of a novel class of protein kinases, with an unusual substrate specificity, which may be involved in cell cycle control. Overexpression of CLK2 decreases cell cycle length. Inhibition of CLK2 may reversibly arrest the cell cycle and tumor growth. GenBank NM_003993
Target Class:
Kinase
Family:
CMGC Kinase
Accession Number:
NM_003993
Target Name:
CLK2
Target Aliases:
CLK2
Target Species:
Human
Usage
Product Type:
Enzymes
Application:
Drug Discovery & Development
Storage Conditions:
6 months at -70°C
Usage Disclaimer:
These products may be covered by issued US and/or foreign patents, patent application and subject to Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information.

Datasheets

14-774x Datasheet

View Document